drugset / Trial / NCT00003031

Comparison of Voriconazole and Amphotericin B in Treating Patients With Aspergillosis

NCT00003031

RandomizedSupportive care

Summary

RATIONALE: Antifungal therapy with voriconazole or amphotericin B may be an effective treatment for aspergillosis. It is not yet known whether voriconazole is more effective than amphotericin B in treating patients with aspergillosis. PURPOSE: Randomized phase III trial to compare the effectiveness of voriconazole with amphotericin B in treating patients with aspergillosis.

Timeline

Start
1997-06
Primary completion
2000-10
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Voriconazole Small molecule Intravenous
Subject amphotericin B deoxycholate Unknown Intravenous

Indications